544 related articles for article (PubMed ID: 6187819)
1. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
[TBL] [Abstract][Full Text] [Related]
2. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
Weston KM; Yeh ET; Sy MS
J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283
[TBL] [Abstract][Full Text] [Related]
3. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice.
Wofsy D
J Immunol; 1986 Jun; 136(12):4554-60. PubMed ID: 3086436
[TBL] [Abstract][Full Text] [Related]
4. Studies of lymphoproliferation in MRL-lpr/lpr mice.
Smathers PA; Santoro TJ; Chused TM; Reeves JP; Steinberg AD
J Immunol; 1984 Oct; 133(4):1955-61. PubMed ID: 6332142
[TBL] [Abstract][Full Text] [Related]
5. Unique surface phenotype of T cells in lymphoproliferative autoimmune MRL/Mp-lpr/lpr mice.
Takei F
J Immunol; 1984 Oct; 133(4):1951-4. PubMed ID: 6332141
[TBL] [Abstract][Full Text] [Related]
6. A new lymphocyte surface antigen defined by a monoclonal antibody (9F3) to the T cell population expanding in MRL/Mp-lpr/lpr mice.
Dumont FJ; Habbersett RC; Nichols EA
J Immunol; 1984 Aug; 133(2):809-15. PubMed ID: 6234361
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous production of interleukin 3 by T lymphocytes from autoimmune MRL/MP-lpr/lpr mice.
Palacios R
Eur J Immunol; 1984 Jul; 14(7):599-605. PubMed ID: 6430708
[TBL] [Abstract][Full Text] [Related]
8. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Burns WH; Prendergast RA
Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):246-50. PubMed ID: 8550330
[TBL] [Abstract][Full Text] [Related]
9. Treatment of murine lupus with monoclonal anti-T cell antibody.
Wofsy D; Ledbetter JA; Hendler PL; Seaman WE
J Immunol; 1985 Feb; 134(2):852-7. PubMed ID: 3871218
[TBL] [Abstract][Full Text] [Related]
10. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
Giese T; Davidson WF
J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
[TBL] [Abstract][Full Text] [Related]
11. Treatment of autoimmune MRL/lpr mice with anti-B220 monoclonal antibody reduces the level of anti-DNA antibodies and lymphadenopathies.
Asensi V; Kimeno K; Kawamura I; Sakumoto M; Nomoto K
Immunology; 1989 Oct; 68(2):204-8. PubMed ID: 2478453
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of murine T cells via the Ly-6C antigen: lack of proliferative response in aberrant T cells from lpr/lpr and gld/gld mice despite high Ly-6C antigen expression.
Dumont FJ
J Immunol; 1987 Jun; 138(12):4106-13. PubMed ID: 2438334
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody (100C5) to the Lyt-2-T cell population expanding in MRL/Mp-lpr/lpr mice detects a surface antigen normally expressed on Lyt-2+ cells and B cells.
Dumont FJ; Habbersett RC; Nichols EA; Treffinger JA; Tung AS
Eur J Immunol; 1983 Jun; 13(6):455-9. PubMed ID: 6602708
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha.
Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD
J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766
[TBL] [Abstract][Full Text] [Related]
15. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
[TBL] [Abstract][Full Text] [Related]
16. Autoreactive T cells in MRL/Mpr-lpr/lpr mice. Characterization of the lymphokines produced and analysis of antigen-presenting cells required.
Weston KM; Ju ST; Lu CY; Sy MS
J Immunol; 1988 Sep; 141(6):1941-8. PubMed ID: 3139746
[TBL] [Abstract][Full Text] [Related]
17. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice.
Fukuyama H; Adachi M; Suematsu S; Miwa K; Suda T; Yoshida N; Nagata S
J Immunol; 1998 Apr; 160(8):3805-11. PubMed ID: 9558084
[TBL] [Abstract][Full Text] [Related]
18. Paul-Bunnell antigen in murine T cell differentiation: abnormal expression in MRL/Mp-lpr/lpr mice.
Katagiri T; Tomiyama H; Kano K
J Immunol; 1986 Feb; 136(3):913-9. PubMed ID: 3079803
[TBL] [Abstract][Full Text] [Related]
19. Selective elimination of non-lpr lymphoid cells in mice undergoing lpr-mediated graft-vs-host disease.
Perkins DL; Michaelson J; Glaser RM; Marshak-Rothstein A
J Immunol; 1987 Sep; 139(5):1406-13. PubMed ID: 2887617
[TBL] [Abstract][Full Text] [Related]
20. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
